Boston-based biotech firm Manifold Bio announced on Monday that it will partner with Swiss pharmaceutical giant Roche to develop a drug for neurological disease using technology driven by artificial ...
Shanghai Zhimeng Biopharma Inc. ( "Zhimeng") announced that its self-developed new-generation potassium channel ...
The early-stage pipeline for amyotrophic lateral sclerosis drugs exploded last year. After ALS R&D notched 28 new trial ...
Tiziana Life Sciences is a buy due to its platform optionality and upcoming catalysts that outweigh its dilution risk and ...
A new Northwestern University study using patient nervous tissue and lab-grown human neurons has uncovered how a key disease ...
A new Northwestern University study using patient nervous tissue and lab-grown human neurons has uncovered how a key disease protein, TDP-43, drives overactive nerve cells in the neurodegenerative ...
Testing showed that Gonzalez’ ALS was caused by a mutation in the SOD1 gene (Super Oxide Dismutase 1), which meant she was ...
Recursion, Roche, and its Genentech subsidiary have unveiled a whole-genome map of specialized microglial immune cells that they plan to use toward revealing significant new targets in ...
Pharmaust Limited ( ($AU:NUZ) ) has provided an update. Neurizon Therapeutics Limited has achieved significant milestones, including the FDA ...
Ionis Pharmaceuticals (NASDAQ: IONS) is gearing up to announce its quarterly earnings on Wednesday, 2025-10-29. Here's a quick overview of what investors should know before the release. Analysts are ...
The BioSpace 40 Under 40 winner opens up about his very personal career transformation from wealth management to biotech—and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback